Login to Your Account



Financings Roundup

Supernus Files for $100M IPO to Back CNS Delivery Pipeline

By Trista Morrison


Tuesday, December 28, 2010
The current initial public offering (IPO) window has not proven particularly welcoming for specialty pharmaceutical firms, but that didn't stop Supernus Pharmaceuticals Inc. from joining the queue with a $100 million filing.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription